Let’s See If You Qualify for the Dexcom G7 Sample Program
Eligibility: Adults and children, ages two and up, who live with diabetes treated with insulin are eligible to receive a Dexcom G7 sample. Samples are for new customers only and are limited to one sample per household.
Please answer the following questions:
WARNING: Always read the indications, warnings, precautions, and instructions for the Dexcom G7 CGM System. If you don't you may have inaccurate sensor readings, missed alerts, and might miss a severe low or high glucose event.
The Dexcom G7 Continuous Glucose Monitoring System (Dexcom G7 CGM System or G7) is a glucose monitoring system indicated for continuously measuring glucose in the interstitial fluid in persons age 2 years and older, including pregnant women. The Dexcom G7 CGM System is designed to replace finger pricks blood glucose (BG) testing for treatment decisions. Interpretation of the Dexcom G7 CGM System results should be based on glucose trends and several sequential sensor readings over time. The Dexcom G7 CGM System also aids in the detection of episodes of hyperglycemia and hypoglycemia, facilitating both acute and long-term therapy adjustments. The Dexcom G7 CGM System is intended for use by patients at home and in healthcare facilities.
* If your glucose alerts and readings from the G7 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, Share are trademarks or registered trademarks in the U.S. and may be registered in other countries.
COPYRIGHT © 2023 DEXCOM INC. ALL RIGHTS RESERVED.
COPYRIGHT © 2023 DEXCOM INC. ALL RIGHTS RESERVED.
MAT-0324